{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/60492-0249#drug","name":"Anthrasil","alternateName":"Anthrax immune globulin (human)","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"60492-0249"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125562"}],"activeIngredient":"ANTHRAX IMMUNE GLOBULIN HUMAN","administrationRoute":["INTRAVENOUS"],"dosageForm":"LIQUID","manufacturer":{"@type":"Organization","name":"Emergent BioSolutions Canada Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"PLASMA DERIVATIVE","sameAs":["https://api.morvs.ai/drug-approval/BLA125562","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60492-0249"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T10:11:08.916Z"}}